Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:17:40 EST Sat 13 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:ANIX - ANIXA BIOSCIENCES INC - https://www.anixa.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ANIX - Q1.03.40·3.700.53.58-1.22-25.42,156.58,0928,0975.00  5.10  3.525.455  2.0719:50:10Dec 1115 min RT 2¢

Recent Trades - Last 10 of 8097
Time ETExPriceChangeVolume
19:50:10Q3.6201-1.1799166
19:32:04Q3.62-1.181
19:31:28Q3.58-1.2235
19:08:48Q3.58-1.22173
18:59:32Q3.5718-1.228265
18:51:58Q3.57-1.23386
18:28:25Q3.5706-1.22943
18:27:40Q3.57-1.2340
18:24:06Q3.57-1.2359
18:18:53Q3.5702-1.229828

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-11 18:02U:ANIXNews ReleaseAnixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
2025-12-10 09:00U:ANIXNews ReleaseAnixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
2025-11-17 08:15U:ANIXNews ReleaseAnixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
2025-11-12 09:00U:ANIXNews ReleaseAnixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
2025-11-10 10:30U:ANIXNews ReleaseAnixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
2025-11-05 08:55U:ANIXNews ReleaseAnixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
2025-10-23 08:45U:ANIXNews ReleaseAnixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
2025-10-20 08:25U:ANIXNews ReleaseAnixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
2025-10-07 08:30U:ANIXNews ReleaseAnixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
2025-09-22 08:05U:ANIXNews ReleaseCleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
2025-09-08 08:00U:ANIXNews ReleaseAnixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
2025-09-02 08:54U:ANIXNews ReleaseAnixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-25 09:13U:ANIXNews ReleaseAnixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-20 08:37U:ANIXNews ReleaseAnixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
2025-08-18 09:00U:ANIXNews ReleaseAnixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
2025-08-12 08:05U:ANIXNews ReleaseAnixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology
2025-08-08 09:15U:ANIXNews ReleaseAnixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
2025-08-04 08:45U:ANIXNews ReleaseAnixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
2025-07-30 08:15U:ANIXNews ReleaseAnixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
2025-07-24 08:00U:ANIXNews ReleaseAnixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s